Dimensional Fund Advisors LP Has $3.44 Million Stock Holdings in Aehr Test Systems $AEHR

Key Points

• Dimensional Fund Advisors reduced its Aehr Test Systems stake by 14.7%, selling 16,030 shares and retaining 93,037 shares worth approximately $3.45 million. Institutional investors collectively own 69.69% of AEHR.
• Aehr reported strong demand tied to AI infrastructure, including a $22 million follow-on order, record quarterly bookings of $60.7 million and an effective backlog of about $100.6 million. The company projects fiscal 2027 revenue of $130 million to $150 million.
• AEHR shares have surged near their 12-month high, but the stock’s demanding valuation and recent insider selling—including 23,000 shares sold in the last quarter—could increase downside risk if growth expectations are not met.

Dimensional Fund Advisors LP trimmed its holdings in Aehr Test Systems (NASDAQ:AEHR - Free Report) by 14.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 93,037 shares of the semiconductor company's stock after selling 16,030 shares during the period. Dimensional Fund Advisors LP owned about 0.30% of Aehr Test Systems worth $3,445,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Aehr Test Systems in the fourth quarter worth approximately $25,000. Sunbelt Securities Inc. purchased a new position in shares of Aehr Test Systems during the third quarter valued at approximately $27,000. State of Wyoming purchased a new position in shares of Aehr Test Systems during the second quarter valued at approximately $28,000. KBC Group NV purchased a new position in shares of Aehr Test Systems during the first quarter valued at approximately $30,000. Finally, Russell Investments Group Ltd. grew its holdings in Aehr Test Systems by 3,500.0% during the third quarter. Russell Investments Group Ltd. now owns 2,448 shares of the semiconductor company's stock worth $74,000 after buying an additional 2,380 shares in the last quarter. 69.69% of the stock is owned by institutional investors.

Aehr Test Systems News Summary

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Aehr received a $22 million follow-on production order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The order expands the customer’s production capacity and reinforces Aehr’s exposure to artificial intelligence and high-performance computing demand. Aehr receives $22 million follow-on order
• Positive Sentiment: The company’s recent operating update showed record quarterly bookings of $60.7 million, an effective backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. The order visibility has strengthened expectations for substantial future growth. Aehr Test Systems stock outlook
• Positive Sentiment: Investors are also focusing on Aehr’s growing role in AI infrastructure, including wafer-level testing for silicon photonics, optical interconnects and next-generation chip-to-chip connectivity. These markets could provide additional long-term growth opportunities. Aehr silicon photonics order and backlog
• Neutral Sentiment: Reported short interest was zero shares, implying little conventional short-covering pressure. However, the figure may be incomplete or anomalous and offers limited investment insight.
• Negative Sentiment: Valuation has become demanding after the stock’s sharp advance, leaving AEHR vulnerable to profit-taking or disappointment if orders and growth targets are not achieved. Aehr Test Systems valuation risks
• Negative Sentiment: Vice President Alistair Sporck sold 1,000 shares for about $108,490, reducing his holdings by roughly 4.25%. The transaction adds to a broader pattern of insider sales without reported open-market purchases during the past six months. Aehr insider share sale

Aehr Test Systems Stock Up 10.3%

AEHR opened at $129.23 on Thursday. Aehr Test Systems has a twelve month low of $16.38 and a twelve month high of $133.35. The company's 50-day moving average price is $91.98 and its two-hundred day moving average price is $70.33. The stock has a market cap of $4.22 billion, a price-to-earnings ratio of -538.44 and a beta of 3.10.

Insider Buying and Selling at Aehr Test Systems

In other news, Director Howard T. Slayen sold 20,000 shares of Aehr Test Systems stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $108.30, for a total value of $2,166,000.00. Following the completion of the transaction, the director owned 146,367 shares in the company, valued at $15,851,546.10. This trade represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Alistair N. Sporck sold 2,000 shares of the business's stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $100.96, for a total transaction of $201,920.00. Following the completion of the sale, the vice president directly owned 23,547 shares in the company, valued at approximately $2,377,305.12. This trade represents a 7.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,000 shares of company stock valued at $2,476,410 in the last quarter. 6.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on AEHR. Weiss Ratings lowered Aehr Test Systems from a "sell (d)" rating to a "sell (e+)" rating in a research report on Wednesday, July 29th. Craig Hallum reissued a "buy" rating and set a $125.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Lake Street Capital restated a "buy" rating and set a $110.00 price target on shares of Aehr Test Systems in a report on Wednesday, July 15th. Freedom Capital raised shares of Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a research report on Thursday, July 16th. Finally, Zacks Research upgraded shares of Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $117.50.

Aehr Test Systems Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source